TransCon hGH (ACP-001)

· Ascendis Pharma A/S

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TransCon hGH (ACP-001), covering 2017-01-19 to 2017-03-09. Get the full timeline:

Most recent: Clinical Trial Update: A Safety, Pharmacokinetic and Pharmacodynamic Study of ACP-001 (TransCon hGH) in Adults With Growth Hormone Deficiency [Phase 2]

See pricing